Class / Patent application number | Description | Number of patent applications / Date published |
514693000 | Aldehyde DOAI | 73 |
20080319088 | Aldehyde Compositions and Methods for Providing Fragrance Containing the Same - The present invention is directed to the novel aldehyde compounds, represented by the general structure of Formula I set forth below: | 12-25-2008 |
20090111894 | Method of Preventing Microbial Growth - There is provided a method of preventing microbial growth in an article, such as a consumer product or packaging material, whereby said article is treated with an effective amount of hydroxyacetaldehyde. | 04-30-2009 |
20090156686 | Composition containing higher fatty acid derivative and foods and drinks - An object of the invention is to provide a composition containing a higher fatty acid derivative, which can be easily produced at low cost, is effective as an agent for prevention and treatment of osteoporosis induced by various factors such as diet, dietary restriction, etc., is highly safe, and can be used regularly; and foods and drinks comprising the composition, which is effective as an agent for prevention and treatment of osteoporosis induced by various factors such as diet, dietary restriction, etc., and suitable as foods and drinks for hospitals, healthy drinks or foods, feeds, etc. | 06-18-2009 |
20120252902 | TREATMENT OF ADHD - A method is provided for treating a subject in need of therapy for attention deficit hyperactivity disorder (ADHD) and related CNS disorder symptoms of impaired learning, impaired planning, impaired problem solving, impulsiveness attention deficit and aggression comprising administering to said subject an amount of a ketogenic material sufficient to produce a ketosis in the subject sufficient to provide therapeutic benefit in such behavioural disorders. Preferred materials produce a ketosis is such that the total concentration of acetoacetate and (R)-3-hydroxybutyrate in the blood of the subject is raised to between 0.1 and 30 mM. | 10-04-2012 |
20140057992 | CONTROLLED ACTIVATION OF THE REUTERIN-PRODUCTION MACHINERY OF LACTOBACILLUS - Methods for the controlled activation of the reuterin-production machinery of | 02-27-2014 |
20140107220 | OCTAHYDRO-1H-4,7-METHANO-INDENE-5-ALDEHYDES AND THEIR USE IN PERFUME COMPOSITIONS - The present invention is directed to a novel fragrance compound of octahydro-4,7-methano-1H-indene-5-acetaldehyde. | 04-17-2014 |
20140107221 | OCTAHYDRO-1H-4,7-METHANO-INDENE-5-ALDEHYDES AND THEIR USE IN PERFUME COMPOSITIONS - The present invention is directed to a novel fragrance compound of octahydro-6-methyl-4,7-methano-1H-indene-5-carboxaldehyde. | 04-17-2014 |
20150148429 | Pain Relieving System - An inventive composition including an amount of sugar or sugar alcohol, an amount of alkalizing agent, and an amount of vehicle; whereby the inventive composition is formulated for transdermal administration to alleviate one or more disorder symptoms, for example neurogenic pain, or to treat one or more disorders, for example neurogenic inflammation. | 05-28-2015 |
514694000 | Formaldehyde | 7 |
20090018210 | A Method for Promoting Fat Degradation - A novel, new, and highly effective agent for promoting fat degradation that contains astaxanthin and/or an ester thereof as active ingredient is provided. The agent for promoting fat degradation of the present invention has an effect of reducing fat by lipolysis of fat in either a subject who is in a condition in which fat has already accumulated or a subject who is in a condition in which fat has not yet been accumulated. Accordingly, the agent for promoting fat degradation of the present invention can restore hypertrophied adipocytes to a normal size. | 01-15-2009 |
20090203800 | Cytostatic Composition - A cytostatic composition comprising an effective amount of an aldehyde in a pharmacological salt solution is shown to be effective at inhibiting growth of a number of cancerous cell lines. | 08-13-2009 |
20100137450 | PROCESS FOR THE PREPARATION OF AQUEOUS FORMALDEHYDE SOLUTIONS - Aqueous formaldehyde solutions are prepared and the formaldehyde content of the aqueous formaldehyde solutions produced is determined by an online analytical method. The desired formaldehyde content can subsequently be established by addition of water so that an aqueous formaldehyde solution having a defined formaldehyde content (formalin) is obtained. | 06-03-2010 |
20100144889 | CHOLESTEROL CONTROL AGENT - The invention relates to medicine and can be used for producing a medicinal agent for normalising the cholesterol level. The aim of the invention is to develop a physiologically acceptable cholesterol-control agent which is nontoxic and does not cause addiction of organism. In preferred embodiments, the method for producing said agent consists in using 2-6 weight parts of a 36.5-40.0% formaldehyde medicinal solution and in adding 998-994 weight parts of a sterile 0.85-0.95% sodium chloride solution which is used for injection in such a way as to produce a 0.07-024% formaldehyde solution. The agent is stored at a temperature of 15-35° C. It also encompasses a method for treatment of patients for lowering their cholesterol levels that comprises administering the agent to the patients as intramuscular injections with a predetermined dose at a predetermined time interval. | 06-10-2010 |
20110118360 | AGENT FOR ACTIVATING STEM CELLS - The invention relates to medicine, in particular to medicinal preparations directed at activating own stem cells of a human body. The aim of the invention is to develop a non-toxic agent which does not produce side effects and is used for activating the stem cells of an organism. The proposed method for producing the agent involves taking a 37-40% medicinal formaldehyde solution and adding it into a 0.9-0.95% sterile sodium chloride solution used for injections in such a way that a 0.00003-0.003% formaldehyde solution is obtained. The agent should be stored in a dark place at a temperature of 15-35° C. | 05-19-2011 |
20120252903 | CHOLESTEROL CONTROL AGENT - There is proposed a method for using a preparation for lowering the cholesterol level of a patient. In preferred embodiments, the preparation essentially consists of an active substance being an aqueous solution of formaldehyde with a concentration of 36.5-40%, the active substance constitutes 2-6 weight units, and an additive being an isotonic solution of sodium chloride with a concentration of 0.85-0.95%, the additive constitutes from 998 to 994 weight units accordingly, to make the total of 1000 weight units. The method includes administering the preparation to the patient in the form of intramuscular injections with a predetermined dose at a predetermined time interval, thereby lowering the cholesterol level of the patient. It is preferable to choose the predetermined time interval from the group consisting of 7, 21, 30, and 60 days. It is also preferable to choose the predetermined dose in the amount of 5 mL. | 10-04-2012 |
514696000 | With alcohol | 1 |
20100190863 | METHOD OF STABILIZING AN ALDEHYDE - A method of manufacturing a stable aldehyde-surfactant complex solution wherein at least one aldehyde is added to a surfactant in a first aliquot of water, at a temperature of between 40° C. to 50° C., the aldehyde is allowed to interact with the surfactant or detergent, in a complexing reaction, for at least 15 minutes whilst maintaining the temperature between 40° C. to 50° C. to produce an aldehyde-surfactant complex solution, and a second aliquot of water is added after at least 15 minutes to cool the aldehyde-surfactant complex solution to below 40° C. to stop the complexing reaction. | 07-29-2010 |
514699000 | Benzene ring containing | 27 |
20080221221 | Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization - Use of 2-bromo-isovanillin in the preparation of an anticancer medicament and/or radio- and chemotherapy sensitizing medicament is disclosed. The medicament for the treatment of cancers and/or for radio- and chemotherapy sensitization comprising 2-bromo-isovanillin as active ingredient provided herein has the following features: (1) low toxicity, without evident adverse effects; (2) significant therapeutic effect, with remarkable proliferation inhibiting and pro-apoptotic effects in tumor cells; (3) a broad-spectrum anticancer activity; (4) suitable to be used in combination with antimetabolites, to enhance the effects and meanwhile lower the toxicity, and also to reduce multi-drug resistance; (5) convenient and safe administration, the main route being oral. | 09-11-2008 |
20090018211 | Method for inhibiting of COX2 and inflammation with phenolic aldehydes - A method for inhibiting of COX2 and inflammation by administering a hydroxybenzaldehyde. | 01-15-2009 |
20090111895 | ENHANCED DIALDEHYDE DISINFECTANT AND STERILIZATION FORMULATIONS - High-level disinfectant formulations and sporicidal formulations suitable for use as chemical disinfection and sterilization mediums comprising a dialdehyde, a carboxylate salt in amount of from about 3 weight percent to about 20 weight percent, and the balance water. The formulations are useful for disinfecting and sterilizing medical instruments and medical equipment. | 04-30-2009 |
20100016443 | METHOD FOR PREPARING PARTICLES COMPRISING METAL OXIDE COATING AND PARTICLES WITH METAL OXIDE COATING - The invention relates to a process for coating a solid, water-insoluble particulate matter, with a metal oxide comprising: (a) contacting the solid, water-insoluble particulate matter with an ionic additive and an aqueous medium to obtain a dispersion of said particulate matter having positive charges on its surface; (b) subjecting the particulate matter to a coating procedure comprising precipitating a metal oxide salt onto the surface of the particulate matter to form a metal oxide layer thereon to thereby obtain particulate matter coated by a metal oxide coating layer; (c) repeating step (b) at least 4 more times; and (d) aging said coating layer. The invention further relates to particles comprising a particulate matter coated by a metal oxide layer, to a use of the particles for topical administration, and to a method for preventing, reducing, or eliminating pests at a locus, using the particles. | 01-21-2010 |
20110098362 | Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization - Use of 2-bromo-isovanillin in the preparation of an anticancer medicament and/or radio- and chemotherapy sensitizing medicament is disclosed. The medicament for the treatment of cancers and/or for radio- and chemotherapy sensitization comprising 2-bromo-isovanillin as active ingredient provided herein has the following features: (1) low toxicity, without evident adverse effects; (2) significant therapeutic effect, with remarkable proliferation inhibiting and pro-apoptotic effects in tumor cells; (3) a broad-spectrum anticancer activity; (4) suitable to be used in combination with antimetabolites, to enhance the effects and meanwhile lower the toxicity, and also to reduce multi-drug resistance; (5) convenient and safe administration, the main route being oral. | 04-28-2011 |
20110230565 | NOVEL COMPOUND CONTAINING VANILLIN AND ETHYLVANILLIN, AND PREPARATION AND APPLICATIONS THEREOF - A compound that includes vanillin and ethylvanillin, and a method for making same are described. The compound described can be obtained by the co-crystallisation of vanillin and ethylvanillin. Methods of using the compound in numerous applicable fields, particularly in human and animal food are also described. | 09-22-2011 |
20120157546 | Compositions Containing Aromatic Aldehydes and Their Use in Treatments - Disclosed are pharmaceutical and cosmetic compositions containing aromatic aldehyde compounds. Some of the disclosed compositions are useful as topical therapeutics for treating inflammatory dermatologic conditions. Some of the compositions are useful in transdermal and other systemic dose forms for treating other inflammatory conditions in mammals. | 06-21-2012 |
20120190753 | Compositions Containing Aromatic Aldehydes and Their Use in Treatments - Disclosed are pharmaceutical and cosmetic compositions containing aromatic aldehyde compounds. Some of the disclosed compositions are useful as topical therapeutics for treating inflammatory dermatologic conditions. Some of the compositions are useful in transdermal and other systemic dose forms for treating other inflammatory conditions in mammals. | 07-26-2012 |
20130018107 | Cinnamaldehyde and Diallyl Disulfide Formulations and Methods of Use - The present invention relates to agricultural emulsion concentrates which form stable oil-in-water emulsions when diluted with water. More specifically, the invention relates to stable oil-in-water emulsions which include cinnamaldehyde and diallyl disulfide with a Calsogen® EH and Surfonic® CO 36 emulsion system. The increased stability of the emulsion allows for efficient mixing of the emulsion ingredients and effective storage and application of the cinnamaldehyde and diallyl disulfide to areas in need of nematode protection or treatment. | 01-17-2013 |
20140243421 | BIOLOGICALLY ACTIVE COMPOSITIONS CONTAINING PHENOLIC RESIDUE - A composition for controlling pests. The composition includes an aqueous mixture of at least one phenolic aldehyde and a bisulfite salt with a suitable surfactant and a sufficient amount of the bisulfite salt to solubilize the aldehyde(s). A stable apparent solution is formed. | 08-28-2014 |
20140329909 | SMALL MOLECULE XANTHINE OXIDASE INHIBITORS AND METHODS OF USE - Small molecule xanthine oxidase inhibitors are provided, as well as methods for their use in treating gout or hyperuricemia. | 11-06-2014 |
20140364508 | Small Molecule Xanthine Oxidase Inhibitors and Methods of Use - Small molecule xanthine oxidase inhibitors are provided, as well as methods for their use in treating gout or hyperuricemia. | 12-11-2014 |
20140378552 | Small Molecule Xanthine Oxidase Inhibitors and Methods of Use - Small molecule xanthine oxidase inhibitors are provided, as well as methods for their use in treating gout or hyperuricemia. | 12-25-2014 |
20150051294 | Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative Diseases - The subject invention pertains to myricanol derivatives, therapeutic compositions, and methods for treatment of neurodegenerative diseases, in particular, neurodegenerative diseases associated with abnormal accumulation of protein tau. | 02-19-2015 |
20150327583 | SENSATION MASKING COMPOSITION - The present invention provides masking compositions that include a lower alkyl carboxylic acid, e.g. acetic acid. Also provided is a masking composition that includes (a) a lower alkyl carboxylic acid (e.g. acetic acid), a warming sensate (e.g. vanillin or vanillyl butyl ether) and/or a cooling sensate (e.g. menthol or isopulegol). | 11-19-2015 |
20160151304 | COMPOSITIONS AND METHODS USING CUMINALDEHYDE | 06-02-2016 |
20160157479 | ANTIFUNGAL COMPOSITION AND METHOD - A composition comprising a surfactant, a co-surfactant, and a vanillin or an analogue thereof, that can be used to inhibit the growth of fungus on plants. The composition is diluted with water to form an oil-in-water microemulsion which can be applied to plants to inhibit the growth of fungus on plants. | 06-09-2016 |
20160175264 | COMPOSITIONS AND METHODS USING P-ANISALDEHYDE | 06-23-2016 |
514700000 | Polycyclo ring system | 2 |
20090030088 | Therapeutic benefits of gossypol, 6-methoxy gossypol, and 6,6'-dimothxy gossypol - 6-methoxy gossypol and 6,6′-dimethoxy gossypol were isolated from cottonseeds. Bioactivities of these two gossypol derivatives and gossypol were investigated regarding their antioxidant activities, DNA damage prevention ability, anti-cancer, and anti-trypanosomal activities. Both methoxy compounds had nearly equivalent bioactivities, but gossypol showed greater bioactivities than either methoxy derivative on free radical scavenging activity, reducing power, and DNA damage prevention ability. Gossypol and its methoxy derivatives inhibited growth of three cancer cell lines, i.e., SiHa (cervical cancer), MCF-7 (breast cancer) and Caco-2 (colon cancer) cells, in a dose dependent manner. These three compounds also significantly inhibited growth of trypanosome | 01-29-2009 |
20100286284 | 5-[1'-(DECAHYDRO-7-HYDROXY-1,1,3A,7-TETRAMETHYL-1H-CYCLOPROPA[A]NAPHTHALEN- -4-YL)-3'-METHYLBUTYL]-2,4,6-TRIHYDROXY-1,3-BENZENEDICARBOXALDEHYDE AS MEDICAMENTS - The present invention relates to new compounds of formula (I) and to their use as medicaments. Preferably, the said compounds are used in the preparation of a medicament or food supplement intended for the treatment and/or prevention of ailments or pathologies ensuing from a disorder of the reuptake of the following neurotransmitters: dopamine, serotonin and/or noradrenaline. | 11-11-2010 |
514701000 | Acyclic carbon to carbon unsaturation | 7 |
20080300318 | Cinnamaldehyde formulations and methods of use - The invention generally relates to various cinnamaldehyde (cinnamic aldehyde) formulations for protecting plants from nematodes and other pathogens. The invention provides specific formulations which do not require the use of chemical additives. These formulations have low phytotoxicity and low volatility. Also, methods of applying the formulations for agricultural use are disclosed. | 12-04-2008 |
20080312337 | Anticancer Composition Comprising Obovatol or Obovatal - Disclosed herein is an anticancer composition, comprising obovatol, represented by the following Chemical Formula 1, obovatal, represented by the following Chemical Formula 2, and/or pharmaceutical salts thereof. The composition exhibits the activity of inhibiting the growth of cancer cells and suppressing the expression and activity of matrix metalloproteinases (MMPs), and thus can be useful for the prophylaxis and treatment of cancer as well as for the inhibition of cancer metastasis. | 12-18-2008 |
20090258950 | NON-TOXIC INSECTICIDE - A non-toxic insecticidal composition includes a base horticultural oil, an emulsifier such as potassium salts of fatty acids, cinnamaldehyde and eugenol. | 10-15-2009 |
20100099777 | Cinnamaldehyde - Allicin Compositions and Their Method of Use - The invention generally relates to mixtures of cinnamaldehyde (cinnamic aldehyde) and allicin (10%) in emulsifiable suspension formulations at ratios ranging from 1:1 to 20:1 for protecting plants from damage by nematodes, fungal pathogens, insects and mites. The nematicidal compositions described are easily flowable, easily mixable in water and have low volatility and exhibit no phytotoxicity. Methods of applying the compositions for agriculture use are disclosed. | 04-22-2010 |
20100249244 | METHODS AND COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES AND CONDITIONS - The presently claimed and disclosed inventive concept(s) contemplates compositions comprising compounds, in particular dihydroeugenol (DHE) and/or isoeugenol (IE) and/or ethyl vanillin (EV) or salts, esters, ethers, or derivatives thereof, and methods for topically or systemically delivering them for treatment against inflammation-related and other dermatological conditions such as described herein. These DHE and/or IE and/or EV or salts, esters, ethers or derivatives thereof also are delivered to a measurable extent transepidermally or transdermally. In one of its method aspects, this presently claimed and disclosed inventive concept(s) is directed to a method for treating a patient with a dermatological disease or condition by topically administering to said patient a pharmaceutical or cosmetic composition comprising a pharmaceutically or cosmetically acceptable topical carrier and an effective dermatological disease, disorder or condition-treating amount of a formulation of DHE and/or IE and/or EV, or salts, esters, ethers, or derivatives thereof. In particular, the presently claimed and disclosed inventive concept(s) is directed to a method of using a composition comprising one or more of DHE and/or IE and/or EV or salts, esters, ethers, or derivatives for treating dermatologic diseases, disorders or conditions, aging effects related to decreasing production of collagen, elastin, or hyaluronic acid, or to hyperpigmentation. The formulations may further contain cinnamaldehyde. | 09-30-2010 |
20110301246 | ANTIFUNGAL COMPOSITIONS FOR INHIBITING GROWTH OF WOOD DECAY FUNGI AND USE THEREOF - The present invention is related to an antifungal composition for the inhibition of wood decay caused by wood rot fungi. The invention further comprises a method for the inhibition of wood decay with gallates. | 12-08-2011 |
20140323583 | CINNAMALDEHYDE AND DIALLYL DISULFIDE FORMULATIONS AND METHODS OF USE - The present invention relates to agricultural emulsion concentrates which form stable oil-in-water emulsions when diluted with water. More specifically, the invention relates to stable oil-in-water emulsions which include cinnamaldehyde and diallyl disulfide with a Calsogen® EH and Surfonic® CO 36 emulsion system. The increased stability of the emulsion allows for efficient mixing of the emulsion ingredients and effective storage and application of the cinnamaldehyde and diallyl disulfide to areas in need of nematode protection or treatment. | 10-30-2014 |
514703000 | Carbon to carbon unsaturation | 21 |
20090018212 | METHODS OF RELIEVING STRESS - Methods, combinations and compositions for relieving or preventing the effects of stress are provided. In particular, combinations and compositions comprising cis-3-hexen-1-ol, trans-2-hexenal and α-pinene, articles of manufacture impregnated with the combination or composition and methods of relieving stress by exposure to the combination or composition are described. | 01-15-2009 |
20110046234 | Retinaldehyde in the Treatment of Obesity, Diabetes and Other Conditions - The present invention is directed to methods of treating a patient for a disease or condition associated with adipogenesis or insulin resistance by administering a retinaldehyde compound to the patient or a compound that increases endogenous retinaldehyde levels by inhibiting the enzyme retinaldehyde dehydrogenase 1. | 02-24-2011 |
20110136918 | Methods of Treating Infectious Diseases - The present invention provides methods of treating a human or other mammal infected with a parasitic microorganism by administering an effective amount in unit dosage form of a C | 06-09-2011 |
20120041073 | STABILIZED MUTANT OPSIN PROTEINS - Methods and compositions for stabilizing opsin protein in a vertebrate visual system are provided by administration of opsin-binding synthetic retinoids. | 02-16-2012 |
20120046367 | ESSENTIAL OIL COMPOSITION WITH ANTI-FREE RADICAL ABILITY - Disclosed is an essential oil composition with anti-free radical ability, which includes dl-Citronellol, Eugenol, cis/trans-Citral, Eugenol Methyl Ether and Thymol. It is confirmed that the essential oil composition of the present invention has superior anti-free radical ability and anti-oxidative ability according to the indices including DPPH free radical scavenging ability, ABTS | 02-23-2012 |
20120309848 | NOVEL USES OF NONENAL - The present invention relates to a method for preventing or treating dyslipidemia or fatty liver, comprising: administering to a mammalian subject in need thereof a therapeutically effective amount of a composition comprising nonenal. The present composition containing nonenal as an active ingredient is very effective in preventing or treating obesity, diabetes, dyslipidemia, fatty liver or insulin resistance syndrome (preferably, dyslipidemia or fatty liver, more preferably hyperlipidemia or fatty liver). The composition of the present invention useful as pharmaceuticals compositions or functional food compositions has therapeutic efficacies for obesity, diabetes, hyperlipidemia or fatty liver, and also induces significant decrease in fasting glucose level and blood insulin level to improve type 2 diabetes, insulin resistance and related metabolic disorders. | 12-06-2012 |
20120322891 | RETINOID REPLACEMENTS AND OPSIN AGONISTS AND METHODS FOR THE USE THEREOF - Compositions of and methods for using synthetic retinoids as retinoid replacements and opsin agonists are provided. | 12-20-2012 |
20130072568 | RETINOID REPLACEMENTS AND OPSIN AGONISTS AND METHODS FOR THE USE THEREOF - Compositions of and methods for using synthetic retinoids as retinoid replacements and opsin agonists are provided. | 03-21-2013 |
20130072569 | RETINOID REPLACEMENTS AND OPSIN AGONISTS AND METHODS FOR THE USE THEREOF - Compositions of and methods for using synthetic retinoids as retinoid replacements and opsin agonists are provided. | 03-21-2013 |
20130072570 | Interomone Compositions and Their Use to Modify Behavior in Different Vertebrate Species - A composition comprising an interomone is described for the modification of undesirable or harmful stress-related behaviors or other behaviors or physiology in a variety of vertebrate species, as well as methods of using the compositions in vertebrates from a species different than the species in which the interomone is a naturally occurring pheromone. | 03-21-2013 |
20130210927 | Method of Administering an Interomone to an Animal to Modify the Animals Behavior over an Extended Period of Time - A device or collar having a matrix into which an interomone is incorporated in an amount from between about 0.001% and about 5% by weight of the device is described for the modification of undesirable or harmful stress-related behaviors or other behaviors of physiology in a variety of vertebrate species over an extended period of time, as well as methods of using the device to modify behaviors of a variety of vertebrate species over an extended period of time. | 08-15-2013 |
20130261191 | USE OF ESSENTIAL OIL COMPOUNDS AS HISTOMONASTAT - Essential oil compounds, such as p-cymene, thymol, salicylaldehyde, tea tree oil, peppermint oil, cuminaldehyde, cinnamic acid, cinnamic alcohol, farnesal and farnesylacetone, especially 2-decenal and nerolidol when added to feed or drinking water to combat | 10-03-2013 |
20130310463 | Aromatase Activator - Provided is a material safely promoting the production of estrogen in a living body. The invention relates to use of a compound represented by the following formula (I) or a solvate thereof for producing an aromatase activator. The invention relates to an aromatase activation method comprising administering a compound represented by the following formula (I) or a solvate thereof (wherein the dashed line indicates that the bond may be a double bond, provided that a and b in the formula (I) do not simultaneously represent a double bond). | 11-21-2013 |
20140256826 | TOPICAL USE OF AN ANTIMICROBIAL FORMULATION - The present document describes a method of reducing a microbial presence on at least one part of a subject by topically contacting the subject's part with an antimicrobial formulation comprising: a) at least one antimicrobial isolated or synthetic phenolic compound of natural origin; b) at least one surfactant sufficient to form a solution or dispersion of said phenolic compound in an aqueous carrier; c) a solvent for dissolving said phenolic compound; and d) a sufficient aqueous carrier quantity to make 100% (w/w). | 09-11-2014 |
20140343167 | USE OF CITRAL FOR TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS - The present invention relates to a new use of citral for manufacturing a medicament for treating focal segmental glomerulosclerosis (FSGS). Particularly, the present invention discloses that citral is effective in alleviating symptoms of FSGS, including reducing glomerular epithelial hyperplasia lesions (EPHLs), peri-glomerular inflammation or glomerular hyalinosis or sclerosis, and also reducing proteinuria or hematuria or lowering serum urea nitrogen level or serum creatinine level in the subject. | 11-20-2014 |
20150011649 | METHODS OF TREATING INFECTIOUS DISEASES - The present invention provides methods of treating a human or other mammal infected with a parasitic microorganism by administering an effective amount in unit dosage form of a C | 01-08-2015 |
20150361020 | 4-HYDROXY-2- METHYL-5-(PROPAN-2-YLIDENE)CYCLOHEX-3-ENECARBALDEHYDE FOR THE PREVENTION AND TREATMENT OF A COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASE - The present invention concerns a pharmaceutical compound having the Formula (1): | 12-17-2015 |
20160045453 | STABILIZED MUTANT OPSIN PROTEINS - Methods and compositions for stabilizing opsin protein, such as a Pro23His mutant opsin protein, in a vertebrate visual system, by administration of opsin-binding synthetic retinoids, are provided. The mutant opsin protein binds to the synthetic retinoid, which stabilizes the mutant opsin protein and/or ameliorates the effects of the mutant opsin protein on the vertebrate visual system. | 02-18-2016 |
20160095812 | ESSENTIAL OIL OF SATUREJA MONTANA WITH A HIGH GERANIOL CONTENT, AND USE FOR TREATING GREASY SKIN AND/OR THE ASSOCIATED AESTHETIC DEFECTS - The present invention relates to an essential oil of | 04-07-2016 |
20160151303 | COMPOSITIONS AND METHODS USING TIGLIC ALDEHYDE | 06-02-2016 |
20160199318 | Anti-Viral Compound and Composition | 07-14-2016 |
514705000 | Plural C=O groups | 10 |
20090088483 | AQUEOUS SUSPENSIONS OR DISPERSIONS OF INORGANIC PIGMENTS CONTAINING A MIXTURE CONSISTING OF DIALDEHYDES AND FORMALDEHYDE CLEAVERS - The invention relates to aqueous suspensions or dispersions (slurries) of minerals and/or fillers and/or pigments containing one or more dialdehydes and one or more formaldehyde cleavers, and to the use of mixtures consisting of one or more dialdehydes and of one or more formaldehyde cleavers for stabilizing aqueous suspensions or dispersions of minerals and/or fillers and/or pigments (slurries) with regard to infestation or deterioration by microorganisms. | 04-02-2009 |
20100137451 | COMPOSITIONS AND METHODS FOR TREATING HOOF DISEASES - The present invention is generally directed to compositions and methods for the treatment of an infectious disease of the foot of an animal. One aspect of the invention is directed to a method for preventing and/or treating one or more infectious diseases of the hoof in animals, comprising: preparing a copper-free and zinc-free composition comprising at least one cross-linking agent, wherein the cross-linking agent is not formaldehyde; and administering the composition to a lower leg and hoof area of said animal to prevent and/or treat said one or more infectious diseases. Another aspect of the invention is directed to a copper-free and zinc-free composition for the treatment and/or prevention of one or more infectious diseases of the hoof in animals, comprising at least one cross-linking agent, wherein said cross-linking agent is not formaldehyde. The present invention is also directed to a method for treating and/or preventing papillomatous digital dermatitis in an ungulate, comprising: preparing a copper-free and zinc-free composition comprising at least one cross-linking agent and at least one quaternary ammonium compound; and spraying or applying in a foam a therapeutically effective amount of said composition to a lower leg and hoof area of said ungulate in order to treat and/or prevent said papillomatous digitial dermatitis. | 06-03-2010 |
20100249245 | STERILIZING COMPOSITION - Disclosed is a sterilizing composition including (i) at least one mono or dialdehyde; (ii) at least one glycol or polyol or derivative thereof; (iii) a non-ionic first surfactant; and (iv) a second surfactant having a cloud point in the range of about 30° C. to 50° C. Also disclosed is a sterilizing composition including (i) at least one mono or dialdehyde; (ii) at least one glycol or polyol or derivative thereof; (iii) a non-ionic first surfactant; and (iv) a second surfactant, wherein the second surfactant is a quaternary ammonium compound. A process for preparing the compositions of the invention is also disclosed. The compositions of the invention are low or substantially non-foaming under high pressure, high temperature conditions, thus allowing maximum benefit from the new, more reliable, generation of automated endoscope reprocessing machines. | 09-30-2010 |
20110201692 | ANTIMICROBIAL FLUSH SOLUTIONS - The present invention provides antimicrobial solutions that comprise at least one alcohol, at least one antimicrobial agent and at least one chelator and/or anticoagulant. Also provided are methods for rapidly reducing a microbe or a virus from surfaces including surfaces of indwelling medical devices and organic surfaces such as skin and sutures, and inorganic surfaces such as hospital equipment, pipelines etc. | 08-18-2011 |
20130096202 | DISINFECTING AND STERILISING SOLUTIONS - The present invention relates to disinfecting and sterilising solutions containing glutaraldehyde. In particular, the invention provides solutions which are stabilised through the use of a unique combination of additives, including a bioflavonoid antioxidant (or other phenolic antioxidant) and an alkyl polyglucoside surfactant. | 04-18-2013 |
20130123369 | COMPOSITION HAVING BIOCIDE ACTIVITY FOR AQUEOUS PREPARATIONS - The present invention refers to a process for bacterial stabilizing aqueous preparations like e.g. calcium carbonate slurries and a composition which can be used for the biocidal treatment of such aqueous preparations. | 05-16-2013 |
20130172425 | COMPOSITIONS AND METHODS FOR TREATING HOOF DISEASES - The present invention is generally directed to compositions and methods for the treatment of an infectious disease of the foot of an animal. One aspect of the invention is directed to a method for preventing and/or treating one or more infectious diseases of the hoof in animals, comprising: preparing a copper-free and zinc-free composition comprising at least one cross-linking agent, wherein the cross-linking agent is not formaldehyde; and administering the composition to a lower leg and hoof area of said animal to prevent and/or treat said one or more infectious diseases. Another aspect of the invention is directed to a copper-free and zinc-free composition for the treatment and/or prevention of one or more infectious diseases of the hoof in animals, comprising at least one cross-linking agent, wherein said cross-linking agent is not formaldehyde. The present invention is also directed to a method for treating and/or preventing papillomatous digital dermatitis in an ungulate, comprising: preparing a copper-free and zinc-free composition comprising at least one cross-linking agent and at least one quaternary ammonium compound; and spraying or applying in a foam a therapeutically effective amount of said composition to a lower leg and hoof area of said ungulate in order to treat and/or prevent said papillomatous digitial dermatitis. | 07-04-2013 |
20150366819 | COMPOSITIONS AND METHODS FOR TREATING HOOF DISEASES - The present invention is generally directed to compositions and methods for the treatment of an infectious disease of the foot of an animal. One aspect of the invention is directed to a method for preventing and/or treating one or more infectious diseases of the hoof in animals, comprising: preparing a copper-free and zinc-free composition comprising at least one cross-linking agent, wherein the cross-linking agent is not formaldehyde; and administering the composition to a lower leg and hoof area of said animal to prevent and/or treat said one or more infectious diseases. Another aspect of the invention is directed to a copper-free and zinc-free composition for the treatment and/or prevention of one or more infectious diseases of the hoof in animals, comprising at least one cross-linking agent, wherein said cross-linking agent is not formaldehyde. The present invention is also directed to a method for treating and/or preventing papillomatous digital dermatitis in an ungulate, comprising: preparing a copper-free and zinc-free composition comprising at least one cross-linking agent and at least one quaternary ammonium compound; and spraying or applying in a foam a therapeutically effective amount of said composition to a lower leg and hoof area of said ungulate in order to treat and/or prevent said papillomatous digitial dermatitis. | 12-24-2015 |
20160081331 | DISINFECTING AND STERILISING SOLUTIONS - The present invention relates to disinfecting and sterilising solutions containing glutaraldehyde. In particular, the invention provides solutions which are stabilised through the use of a unique combination of additives, including a bioflavonoid antioxidant (or other phenolic antioxidant) and an alkyl polyglucoside surfactant. | 03-24-2016 |
20160136109 | COMPOSITIONS FOR TISSUE STABILIZATION - Collagen crosslinking/stabilization composition optionally in combination with elastin crosslinking composition as treatment of vascular aneurysms, methods of using the compositions, especially with respect to in vivo procedures are described. The treatment is achieved through the delivery of an effective amount of crosslinking/stabilization composition to the site of the aneurysm. The crosslinking/stabilization agent may be embedded in a delivery composition and delivered to the site of aneurysm using a delivery device. The site of the aneurysm may be isolated for treatment using the delivery device. The elastin stabilization agent may be simultaneously or sequentially delivered with the collagen crosslinking/stabilization agent for the treatment of vascular aneurysms in the isolated section of blood vessel. | 05-19-2016 |